BSC Training Course: HPC-based Computational Bio-Medicine: from cell to organ level

Date: 20/Feb/2024 Time: 09:30 - 22/Feb/2024 Time: 14:00

Target group: INTERMEDIATE For trainees with some theoretical and practical knowledge  

Cost: There is no registration fee. The course is free of charge.  

Primary tabs

Tuesday 20th of February 2024: HPC-basics track & Life sciences

9:30 - 11:00 CET “First steps in the HPC environment”. Part I C. Teijeiro-Barjas (SURFsara) & Okba Hamitou (Atos).
This training provides information and tutorials about how to access and perform basic actions on a supercomputer. This session covers a wide range of topics: some theoretical aspects such as the description of the processor architecture, the several levels of code parallelization, and practical aspects such as the batch scheduler usage, compilation and optimization guidelines towards good performance achievements.
11:00 – 11:30 CET Break
11:30 - 13:30 CET “First steps in the HPC environment”. Part II C. Teijeiro-Barjas (SURFsara) & Okba Hamitou (Atos).
 
Wednesday 21st of February 2024: Molecular medicine track & Life sciences
9:30 - 11:25 CET “Molecular Medicine”. Andrea Townsend-Nicholson (UCL). This workshop in molecular medicine aims to provide participants with a theoretical understanding of the importance of the relationship between human microbiomes – the microorganisms present in and on the human body – and human health and with the practical opportunity to use state of the art computational resources to run a metagenomics pipeline. Using marker gene abundance data and the QIIME2 computational workflow, the identity of the different bacterial taxa present in Next Generation Sequence data obtained from medically-relevant microbiome samples will be obtained and the statistical significance of the experimental hypothesis determined.

11:25 – 12:00 CET Break
12:00 - 14:00 CET “Introduction to Computer-Aided Drug Design (CADD)”. Alexander Heifetz (Evotec). The subject of my presentation is application computer-aided drug design (CADD) methods in drug design. CADD is the application of computer modelling techniques to drug design process. I will provide a brief overview of these CADD approaches illustrated by the examples taken from real drug discovery campaigns. In my presentation, I will cover the basic theory behind these methods and describe various techniques like virtual screening, homology modeling, docking, structure- and ligand- based drug design, fragment-molecular orbital (FMO) quantum mechanics analysis of protein-water-ligand interactions, GPCR modeling, structure-activity analysis (SAR) and artificial intelligence/deep learning.
14:00 – 15:00 CET Break
15:00-16:30 CET “The use of multiscale modelling to build a virtual patient from the cell-level up” Arnau Montagud (BSC, PerMedCoE). Multiscale modelling is a versatile methodology that can reconcile cell intracellular events (such as mutation or drug effects) with cell population effects (such as cancer phenotypes or clonal heterogeneity formation). These models are helping researchers address the diseases at the cell level by enabling the study of the consequences of mutations and genomic alterations in specific signalling and metabolic pathways of the different cell types, the modelling of the temporal evolution of the complete tumour and its microenvironment and the prediction of the response to different drugs.In this talk, we will introduce the basics of multiscale modelling (Metzcar et al., 2019), the use of Boolean- logic-based models of signalling pathways (Stoll et al., 2017), and the simulation of tumour evolution with agents representing cell types (Ghaffarizadeh et al., 2018). Specifically, we will present tools to tailor a Boolean model to a given patient’s data (Béal et al., 2019; Montagud, Béal, et al., 2021) and simulate the interplay of genetic and environmental perturbations in the context of cancer cells’ resistance to drugs (Letort et al., 2019; Ponce-de-Leon et al., 2022). Finally, we will present recent advances in using such tools in pre-exascale high-throughput computing clusters to simulate cancer tumours of millions of cells and simulate thousands of patients in optimised analysis pipelines that go from patients’ genomic information to simulation results (Montagud, Ponce-de-Leon, et al., 2021; Saxena et al., 2021).

Thursday 22nd of February 2023: Computational Mechanics track
9:30-11:25 CET "HPC-based simulations for the respiratory system". Silvia Ceccacci (BSC) & Beatriz Eguzkitza(BSC). In this course, we shall explore different aspects of high-performance computing (HPC) simulations focusing on the upper airways and their relevant medical applications. We will start by introducing the incompressible Navier-Stokes equations that govern the airflow dynamics through the nasal cavities, and the equations governing the Lagrangian transport of drug particles. We shall then dive into a specific application of interest for medical doctors. Such application aims at analysing the spatial distribution of drug particles inside the nasal cavities, following intranasal administration via a nasal spray. We will engage in a hands-on exercise using Alya, a multi-physics HPC code developed at BSC, tailored to run efficiently on supercomputers. We will be running simulations on the BSC's supercomputer Marenostrum 4, offering a practical experience in navigating the HPC server environment.
11:25 – 12:00 CET Break
12:00 - 14:00 CET “Zoom in on blood - Using supercomputers for blood flow simulations” Jelle van Dijk (University of Amsterdam). 1 mm^3 of human blood, that is less than a single drop, contains about 5 million cells. The interaction and deformation of these cells give rise to the unique properties of blood. Modern biomedical research (e.g. on drug delivery, effect of various diseases such as diabetic cells or sickle cell disease) builds on this information. Unravelling detailed biomechanical and rheological processes in flowing blood requires an accurate modelling of these deformable cells and the surrounding fluid on microscopic level. In this lecture an open-source package (www.hemocell.eu) will be discussed that on one hand allow us to model the behaviour of single cells accurately, and on the other hand can scale up to the level of large flows with millions of cells.
END of COURSE